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1 Summary 
Rickettsia helvetica, a tick-borne member of the spotted fever group 
rickettsiae, was found to be pathogenic in humans. Its importance in animals is 
unknown. The aims of this study were to establish a R. helvetica specific real-
time TaqMan PCR assay and apply it to analyze tick vectors (potential 
exposure risk) and blood samples from canidae and humans (prevalence of 
infection). The newly designed 23S rRNA gene assay for R. helvetica was 
more sensitive than a published gltA gene assay for several rickettsiae. Blood 
samples from 884 dogs, 58 free-ranging foxes, 214 human patients and 2,073 
ticks (Ixodes spp.) collected either from the vegetation or from animals were 
analyzed. Although 12% of the unfed ticks and up to 40% of the ticks collected 
from animals tested PCR-positive, none of the 1,156 blood samples did. Ticks 
from cats were more frequently PCR-positive than ticks from dogs. 
Sequencing of the 23S rRNA and/or gltA gene of 17 tick pools confirmed the 
presence of R. helvetica. Additionally, a Rickettsia species not yet described in 
Switzerland was identified. In conclusion, R. helvetica was frequently detected 
in the tick population but not in blood samples. Nonetheless, due to the broad 
host range of Ixodes ticks and the high infection rate (i.e. R. helvetica was 
found 13-times more frequently in unfed ticks than TBEV) a wide variety of 
mammals may be exposed to R. helvetica. Our newly developed sensitive 
PCR assay represents an important tool to study this issue.  
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2 Introduction 
Tick-borne rickettsioses are caused by intracellular bacteria belonging to the 
spotted fever group (SFG) of the genus Rickettsia. The latter comprises more 
than 20 different species of which an increasing number have been associated 
with human and animal diseases. Depending on the occurrence of tick-
species, SFG rickettsiae have a worldwide distribution. The most common tick 
in Europe is Ixodes ricinus, which was found to harbor Rickettsia helvetica. R. 
helvetica is transmitted transstadially and transovarially in I. ricinus. Therefore, 
this tick is not only a vector but also a reservoir for R. helvetica. Due to the 
broad host range of I. ricinus, many mammalian species including humans can 
serve as hosts, and, therefore, are potentially exposed to R. helvetica. 
Symptoms described for infections in humans include fever, headache, 
arthralgia, and myalgia (1, 3, 6, 18, 30). The agent also has been implicated in 
two cases of fatal perimyocarditis (17, 19). 
Interestingly, despite the wide distribution of I. ricinus ticks and the high 
infestation rate of these ticks with R. helvetica reported from several European 
countries (2, 8, 15, 16, 22, 26, 30, 31, 38) larger studies about the prevalence 
of the infection in humans and animals are scarce. No studies evaluating the 
importance of R. helvetica in companion and farm animals are yet available. It 
is unknown, whether these animals can serve as reservoir or develop clinical 
signs after infection.  
Rickettsial infections have been reported to represent the third most common 
vector-borne disease acquired during international travel and therefore are 
considered a common cause of fever of unknown origin in returned travelers 
(21). As the occurrence of tick-borne infectious diseases and particularly 
Rickettsia infections are increasing worldwide in human medicine (23), it can 
be assumed that the same holds true for companion animals. In dogs, fever of 
unknown origin but responsive to antibiotic treatment can frequently be 
observed. In these cases, an infectious agent is suspected but rarely, if ever, 
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confirmed. R. helvetica infections might be the underlying cause in some of 
these cases even if the patient does not have a travel history, since the 
exposure to R. helvetica infected I. ricinus ticks might have occurred locally. 
To date, the diagnosis of a rickettsial infection has most often been confirmed 
by serologic testing. However, antibodies are not detectable prior to the 
second week of illness for any of the so far studied rickettsial diseases. 
Moreover, except for detection of seroconversion or a fourfold increase in titer, 
a positive serology does not necessarily indicate an acute infection. A 
standardized sensitive and specific molecular method for the confirmation of 
R. helvetica infections would facilitate not only its diagnosis but also 
prevalence studies. This in turn could increase the awareness of physicians 
and veterinarians if confronted with diseased individuals.  
Therefore, the aims of the present study were first to establish a sensitive real-
time PCR assay specific for R. helvetica; second, to study tick vectors for R. 
helvetica to assess the potential exposure risk for animals and humans and 
third, to evaluate blood samples from canidae and humans to assess the 
occurrence of R. helvetica infections.  
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3 Materials and Methods 
3.1 Arthropods 
To analyze the occurrence of R. helvetica in the Swiss tick population, a total of 
2,073 ticks had been included in the study. The majority of the ticks had been 
described previously and had been microscopically determined or assumed to 
be of the Ixodes sp. (36): this included 1,880 unfed ticks that had been 
collected from the vegetation in the area around Zurich (Pfannenstiel, 
Küsnachter Tobel and Rumensee area), Switzerland, and 188 ticks collected 
from 39 cats and 66 dogs. In addition, five Ixodes sp. ticks had been collected 
from five horses in the Canton of Zurich (Table 1). Furthermore, to determine 
the specificity of the newly designed R. helvetica TaqMan PCR assay, 720 I. 
ricinus ticks collected from the vegetation for an unrelated study and 
differentiated according to sex had been used. They were randomly chosen 
from a larger pool of ticks to consist of 480 males and 240 females. All 
arthropods were stored in liquid nitrogen, at -20°C, or in ethanol at 4°C until 
extraction of nucleic acids (NA). 
 
3.2 Blood samples 
A total of 1,156 blood samples were included in the study. They originated 
from 884 privately owned domestic dogs presented for various reasons at the 
Clinic for Small Animals, Vetsuisse Faculty, University of Zurich, 58 free-
ranging wild foxes and 214 anonymous human patients (Table 1). The canine 
EDTA-anticoagulated blood samples had been described previously (34): they 
had been collected throughout a one year period and 615 (70%) of the 
presented dogs originated from the Canton of Zurich, Switzerland. The foxes 
originated from three different beats in the Canton of Zurich; samples 
consisted of coagulated whole blood or serosanguineous fluids. The 214 
human EDTA-anticoagulated blood samples had been provided by a Hospital 
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in the Canton of Zurich and had been collected for routine diagnostic 
purposes.  
 
3.3 NA extraction 
Some ticks were pooled prior to NA extraction as described (36): pools 
consisted of two to ten arthropods of one species collected from one animal 
(Table 1). All arthropods as well as coagulated whole blood samples were 
mechanically disrupted with sterile scalpel blades and homogenized in a Mixer 
Mill MM 300 device (Retsch GmbH, Haan, Germany). NA extraction was 
performed with the MagNA Pure LC Total Nucleic acid isolation kit (Roche 
Diagnostics, Rotkreuz, Switzerland) or with the DNeasy tissue kit (QIAGEN, 
Hombrechtikon, Switzerland) (Table 1). From EDTA-anticoagulated blood and 
serosanguineous samples, NA was extracted from a volume of 100 µl or 
200 µl using the MagNA Pure LC Total Nucleic acid isolation kit (34). During 
each extraction, negative controls consisting of 200 μl phosphate buffered 
saline were concurrently prepared with each batch of 11 to 15 samples to 
monitor for cross-contamination.  
 
3.4 Real-time PCR assays 
The presence of amplifiable nucleic acids was confirmed for each sample 
using a real-time TaqMan PCR assay specific for the 18S rRNA gene (Applied 
Biosystems, Rotkreuz, Switzerland) on a Rotor-Gene6000 real-time rotary 
analyzer (Corbett, Mortlake, Australia) using 2x TaqMan Fast Universal PCR 
Master Mix (Applied Biosystems) in a total volume of 25µl. An initial 
denaturation of 20 s at 95°C was followed by 45 cycles of 95°C for 3 s and 
60°C for 30 s. In some samples the 18S rRNA assay revealed unexpectedly 
high threshold cycle (Ct) values (≥ 30), which could have been attributable to 
inhibition of the PCR reaction. Inhibition was confirmed by testing a 1:10 
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dilution of the samples: while a higher value of approximately 3.3 Ct values 
higher is expected for an uninhibited PCR (sample diluted 1:10), the Ct values 
obtained from some of our samples were lower after dilution. These samples, 
which contained substances that inhibited PCR reactions in their undiluted 
form, were tested in a 1:10 dilution in subsequent PCR assays. 
Members of the rickettsia spotted fever and typhus groups were identified 
using a previously published real-time TaqMan PCR assay specific for a 74 bp 
fragment of the gltA gene (32). The PCR reactions contained a final 
concentration of 0.2 µM of the primers (CS-F and CS-R) and the probe (CS-P) 
(Table 2), 12.5 µl of the 2x TaqMan Fast Universal PCR Master Mix (Applied 
Biosystems) and 5 µl or 2.5 µl template in a final volume of 25 µl. The gltA 
assay was performed using 60 cycles on a Rotor-Gene6000 real-time rotary 
analyzer (Corbett) with an initial denaturation of 20 s at 95°C was followed by 
60 cycles of 95°C for 3 s and 60°C for 30 s. 
For the detection of R. helvetica, a specific real-time PCR assay based on a 
65 bp fragment of the 23S rRNA (GenBank accession number AY125017) was 
designed: this assay amplified a fragment located in the same region as a real-
time PCR previously described (28). The latter assay was not applied in the 
present study, because the primer and probe sequences and the conditions of 
the PCR run were not suitable for a standard TaqMan real-time PCR assay on 
ABI real-time cyclers. The system used the primers Rickhelv.147f and 
Rickhelv.211r, and the probe Rickhelv.170p (Table 2). The real-time PCR 
reactions contained 12.5 µl of the 2x qPCR MasterMix Plus Low ROX 
(Eurogentec, Seraing, Belgium), a final concentration of 0.9 µM of each primer 
and of 0.25 µM of the probe, 2.5 µl or 5 µl of the template in a total volume of 
25 µl. The R. helvetica-specific real-time PCR assay was performed using the 
ABI PRISM 7500 Sequence Detection System (Applied Biosystems) with an 
initial step of 50°C for 2 min and a denaturation of 95°C for 10 min followed by 
45 cycles of 95°C for 15 s and 60°C for 1 min. In the R. helvetica 23S rRNA 
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PCR runs, the amplification mixture contained dUTP for the use with uracil-N-
glycosylase to prevent carryover of PCR amplicons. In all PCR systems, water 
was used as a negative control. All negative extraction and pipetting controls 
tested PCR-negative. NA from the following bacteria was used to determine 
the specificity of the real-time PCR assays: R. helvetica and Rickettsia africae 
(kindly provided by Dr. R. Wölfel), Rickettsia conorii (kindly provided by Dr. S. 
Casati), Anaplasma phagocytophilum, Ehrlichia canis, Mycoplasma 
haemofelis, ‘Candidatus Mycoplasma haemominutum’, ‘Candidatus 
Mycoplasma turicensis’. For comparison of the prevalence of R. helvetica with 
that of another frequently encountered tick-born pathogen, the 1,880 ticks 
collected from the vegetation in the Canton of Zurich, were additionally 
analyzed by real-time RT-PCR for the presence of the tick-borne encephalitis 
virus (TBEV) as described (35). 
 
3.5 Production of DNA standard  
For absolute quantification, a 330 bp sequence of the 23S rRNA gene of R. 
helvetica (AY125017) enclosing the 65 bp long TaqMan system was amplified 
using the R. helvetica specific primers Rhelv.26f and Rhelv.356r (Table 2). 
The reaction mixture contained 5 μl of 5x Phusion HF buffer (Finnzymes, 
Espoo, Finland), 0.5 μl of Phusion Hot Start DNA polymerase (Finnzymes), a 
final concentration of 0.2 mM of dNTP and of 0.5 µM of each primer; and 2.5 μl 
of template NA in a final volume of 25 μl under the following thermal cycling 
conditions: a denaturation step of 98°C for 3 min was followed by 35 cycles of 
98°C for 10 s, 65°C for 30 s and 72°C for 1 min, with a final extension of 72°C 
for 10 min. The amplified fragment was purified using the Gen Elute PCR 
Clean-Up Kit (Sigma, Fluka GmbH, Buchs, Switzerland) and cloned into the 
TOPO TA Cloning vector (Invitrogen, Basel, Switzerland). The plasmid was 
linearized by restriction digestion using BamHI (Promega, Wallisellen, 
Switzerland), purified (QIAquick Gel Extraction Kit, Qiagen) and the copy 
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number was calculated after both spectrophotometrical (GeneQuant, 
Amersham-Pharmacia Biotech, Otelfingen, Switzerland) and agarose gel 
electrophoresis analysis (Syngene, Gene Tools, Syngene, Cambridge, UK). 
The R. helvetica DNA Standard was serially tenfold diluted in a solution 
containing 30 μg/ml of salmon sperm DNA (Invitrogen), aliquoted and frozen at 
-20°C until use.  
For each serial dilution of the 23S rRNA assay, the slope of the dilutions 
versus threshold cycle curve was assessed as a measure for the amplification 
efficiency. Amplification efficiencies were calculated as (101/ (-slope)-1) (12). 
 
3.6 Sequencing of gltA gene  
To confirm the presence of rickettsiae in PCR-positive samples and analyze 
the prevailing Rickettsia species, sequencing analyses of the gltA gene were 
performed (Fig. 1 and Table 2). Initially, for this purpose a 381 bp PCR 
product was amplified using primers previously described (24) (Fig. 1 and 
Table 2) with the following modifications: the reaction mixture contained 2.5 μl 
of 10x PCR TaqGold Buffer (Applied Biosystems), 0.4 μl of AmpliTaqGold 
Polymerase (Applied Biosystems), 1.5 μl of 25 mM MgCl2, a final 
concentration of 0.2 mM of dNTP and of 0.5 µM of each primer, and 2.5 μl of 
template DNA in a total volume of 25 μl. The thermal cycling conditions were 
as follows: an initial denaturation step of 95°C for 5 min followed by 40 cycles 
of 95°C for 20 s, 56°C for 30 s and 72°C for 1 min, and a final elongation of 
72°C for 5 min. The PCR products were purified (Gen Elute PCR Clean-Up Kit, 
Sigma) and sequenced using the BigDye Terminator v1.1 Cycle Sequencing 
Kit (Applied Biosystems). The reactions were purified using the SigmaSpin 
Post-reaction cleanup Kit (Sigma) and run on an ABI310 sequencer (Applied 
Biosystems).  
In addition, a longer portion of the gltA gene was analyzed using five additional 
published gltA-gene specific PCR assays (24, 27, 29). Primer sequences, 
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length of the five PCR products and according references are given in Fig. 1 
and Table 2. The reaction mixture for the five systems contained 5 μl of 5x 
Phusion HF buffer (Finnzymes), 0.5 μl of Phusion Hot Start DNA polymerase 
(Finnzymes), a final concentration of 0.2 mM of dNTP and of 0.5 µM of each 
primer; and 1.25 μl of template NA in a final volume of 25 μl under the 
following thermal cycling conditions: initial denaturation step of 95°C for 2 min 
followed by 40 cycles of 95°C for 30 s, 45°C for 30 s and 65°C for 55 s, and a 
final elongation of 72°C for 3 min (24). 
 
3.7 Sequencing of the 23S rRNA gene  
In order to further confirm the specificity of the newly established R. helvetica 
23S rRNA TaqMan assays, for the standard production and to confirm PCR-
positive results, two partially overlapping fragments of 206 and 330 bp, 
respectively, were amplified. The primers (Table 2) for these assays were 
designed as follows: for the 206 bp fragment both primers 
(Rhelv.159f/Rhelv.365r) were based on the sequence of R. helvetica 
(AY125017). However, the fragment does not fully enclose the TaqMan 
sequence. For the fragment of 330 bp, which encloses the complete TaqMan 
system, a R. helvetica specific reverse primer, R.helv.356r, was used (Table 
2). The forward primer, Rhelv.26f, was based on a rickettsia consensus 
sequence. The reaction mixture and thermal cycling condition were the same 
as described above for the standard production. PCR products were 
sequenced as described above for the gltA gene, using the PCR amplification 
primers.  
 
3.8 Phylogenetic analyses 
Phylogenetic and molecular evolutionary analyses were conducted using 
MEGA version 3.1 (13). The sequences obtained were compared to known 
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sequences deposited in the GenBank database and percentage identity was 
calculated by pairwise comparison (Kimura 2-Parameter model) (11). The 
sequences were aligned using CLUSTAL W (33) and manually adjusted. Only 
positions where the nucleotide composition was known in all sequences being 
compared were used in the phylogenetic analysis. The phylogenetic tree was 
constructed after trimming of the primer sequences with the neighbor-joining 
method (25) from a distance matrix corrected for nucleotide substitutions by 
the Kimura 2-parameter model. The data set was resampled 1,000 times to 
generate bootstrap values. 
 
3.9 Statistics 
Prevalence and confidence intervals (CI) were calculated as described (37) 
using the open-source program R (http://www.r-project.org/). Rickettsial loads of 
female and male tick pools were compared using the Mann-Whitney U-test (4); the 
NA content of each pool was controlled for using the 18S rRNA gene assay. 
Frequencies of PCR-positive results from ticks collected from cats versus 
those collected from dogs were compared using the Chi2 test (4). Ticks from 
horses were not included in this analysis because of small numbers of ticks (n 
= 5). 
 
3.10 Nucleotide sequence accession numbers 
The partial gltA/23S rRNA gene nucleotide sequences generated from R. helvetica 
isolates have been submitted to GenBank and given the accession numbers 
EU359279-EU359283, EU359285-EU359297 and EU359301 for the gltA-gene and 
EU359273-EU359278 for the 23S rRNA gene. In addition sequences found for the 
tick pool #73 have been submitted to GenBank and given the accession numbers: 
EU359284, EU359298-EU359300 and EU359302. 
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4 Results 
4.1 Specificity of the 23S rRNA gene real-time PCR assay 
A new real-time PCR assay for the detection and quantification of the 23S rRNA 
gene of R. helvetica was designed in this study. To test the specificity of the 
PCR assay, NA of various bacteria were analyzed. They all tested real-time 
PCR-negative with the exception of R. helvetica. To confirm that the PCR 
system did not amplify endosymbionts, which are only present in female ticks, 
24 tick pools consisting of 20 male ticks and 24 pools containing ten female 
ticks were assayed. All pools tested positive using the 23S rRNA real-time 
PCR assay. No significant difference was found in the rickettsial NA load 
between the female and male tick pools using the 23S rRNA real-time PCR 
assay quantitatively (data not shown). To further confirm the specificity of the 
assay and PCR-positive results, five 23S rRNA gene TaqMan PCR-positive I. 
ricinus tick pools collected from the vegetation were sequenced (four PCR 
products of 206 bp and two PCR products of 330 bp; Table 2). All resulting 
sequences were 100% similar to R. helvetica (AY125017).  
 
4.2 Linear range of amplification and sensitivity of the real-time PCR 
assay 
The 23S rRNA gene R. helvetica DNA standard was serially tenfold diluted to 
assess the linear range and sensitivity of the assay. The amplification of the 
serial dilutions showed linearity over eight orders of magnitude and a mean 
efficiency of the assay of 98.8%. The highest dilution still yielding a positive 
signal contained an average of one copy of the standard per reaction; in an 
endpoint dilution experiment, six out of eight replicates (75%) of this dilution 
were positive. 
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4.3 Rickettsia in arthropods collected from the vegetation 
The 188 NA tick pools collected from the vegetation in the area around Zurich, 
Switzerland, were analyzed by the gltA gene real-time PCR for the presence of 
rickettsiae of the spotted fever group and typhus group: 122 out of the 188 
pools tested positive. This calculated into an estimated prevalence of 
rickettsiae of the spotted fever and typhus group of 9.9% (95% CI, 8.3 to 
11.8%; Table 1). 
In addition, arthropods were analyzed by the 23S rRNA gene real-time PCR 
for the presence of R. helvetica NA. Analyzing unfed ticks from the vegetation 
of Switzerland, the majority of the pools (134 out of 188) were found to be 
positive for the 23S rRNA gene. This calculated into an estimated prevalence 
of R. helvetica in the Swiss I. ricinus tick population under investigation of 
11.7% (95% CI, 9.9 to 13.8%; Table 1). 
The readout of the real-time PCR assays, e.g., the 23S rRNA gene and gltA 
gene assays, is the so-called threshold cycle (Ct) value. The Ct value is an 
inverse measure of the template load: the higher the template load, the lower 
the Ct value. Analyzing the 188 tick pools from the vegetation, all of the Ct 
values from the gltA gene real-time PCR assay were higher than the Ct values 
from the 23S rRNA gene real-time PCR assay, except for one tick pool, #73. 
Twelve pools tested positive in the 23S rRNA assay but negative in the gltA 
assay. Tick pool #73 and some additional pools were further analyzed by 
sequencing. 
For comparison, the 188 tick pools have also been analyzed for TBEV: 16 out 
of 188 pools tested positive. This calculated into an estimated prevalence of 
0.9% (95% CI, 0.5 to 1.4%). 
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4.4 Rickettsia in arthropods collected from animals 
Overall, 49 out of 168 arthropod samples (29%), 43 out of 153 ticks (28%) and 
6 out of 15 tick pools, tested real-time PCR-positive with the gltA gene specific 
TaqMan PCR system. When the samples were classified according to the 
animal species they had been collected from, 26 out of 62 (42%) ticks and two 
out of three tick pools from cats were found positive. This calculated in an 
overall sample prevalence of rickettsiae of the spotted fever and typhus group 
in ticks from cats of 40.9% (95% CI, 29.8 to 52.9%; Table 1). Ticks from 18 out 
of 39 cats (46%) were found gltA PCR-positive. For ticks collected from dogs, 
16 out of 86 ticks (19%) and four out of 12 pools containing two to four ticks 
per pool were positive. The sample prevalence in ticks from dogs was 17.6% 
(95% CI, 11.4 to 25.3%; Table 1). Ticks collected from 18 out of 66 (27%) 
dogs tested PCR positive. One out of five ticks (20%) collected from horses 
was positive. Ticks collected from cats were significantly more frequently gltA 
PCR-positive than ticks collected from dogs (pChi2 = 0.0019). In addition, ticks 
from a higher percentage of cats then of dogs were PCR-positive (pChi2 = 
0.0489). 
Overall, 66 of 168 arthropod samples (40%) - 57 out of 153 ticks (37%) and 
nine out of 15 tick pools - collected from animals tested real-time PCR-positive 
for the 23S rRNA gene of R. helvetica. When the samples were classified 
according to the animal species from which they were collected, 32 out of 62 
ticks (51%) and two out of three pools contained three ticks per pool collected 
from cats were positive; the overall sample prevalence for ticks from cats 
calculated into 49.9% (CI, 38.1 to 61.7%; Table 1). Ticks from 21 out of 39 
cats (54%) tested positive. In ticks from dogs, 24 out of 86 (28%) ticks and 
seven out of twelve tick pools tested positive. The sample prevalence in ticks 
from dogs was 28.3% (CI, 20.4 to 37.2%; Table 1). Ticks collected from 27 out 
of 66 dogs (40%) tested positive. One out of 5 ticks (20%) collected from 
horses was positive. Ticks collected from cats were significantly more 
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frequently 23S rRNA gene PCR-positive than ticks collected from dogs (pChi2 
= 0.0033).  
Again, Ct values for the 23S rRNA assay were, with one exception (tick #17), 
lower than those of the gltA assay; 17 samples tested positive using the R. 
helvetica specific 23S rRNA assay but negative in the gltA assay. Tick #17 
could not be further analyzed by sequencing because of a low bacterial load. It 
originated from a Japanese Chin dog nine years of age from the Canton of 
Zurich.  
  
4.5 Rickettsia in blood samples from dogs, foxes and humans 
All 1,156 NA samples extracted from blood samples from dogs, foxes and 
humans in Switzerland tested real-time PCR-negative in the gltA and the 23S 
rRNA gene real-time PCR assays.  
 
4.6 Sequencing results from rickettsiae detected in ticks 
To confirm the gltA PCR-positive results and to determine the Rickettsia 
species, different fragments of the gltA gene were sequenced. A 381 bp long 
PCR product (Table 2 and Fig. 1) was amplified from 10 PCR-positive tick 
pools collected from the vegetation. Nine out of the ten pools yielded a 
sequence with 100% identity to that of R. helvetica (AM418450). In contrast, 
sequencing of the tenth pool, tick pool #73, resulted in a sequence with 16 
mismatches to R. helvetica (AM418450). This sequence was most closely 
related (98-99% identity) to the following Rickettsia species: Rickettsia sp. 
IRS4 (AF141906) found in I. ricinus in Slovakia, Rickettsia monacensis 
(DQ100163) reported in Germany and Rickettsia sp. PoTiR6dt (EF501756) 
from I. ricinus in Portugal.  
For the latter (tick pool #73) and four additional tick pools (#15, #20, #21, #41), 
several other fragments could be amplified and sequenced. For all five pools 
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the 163 bp PCR product and for all but #15 796 bp were amplified (Fig. 1 and 
Table 2). Moreover, for three ticks the fragment of 476 bp and for tick pool #15 
the PCR-product with a length of 353 bp was successfully amplified (Fig. 1 
and Table 2). The sequences that resulted for the additional four tick pools 
(#15, #20, #21, #41) were most similar (98-99%) to R. helvetica (U59723). 
Tick pool #73, however, showed overall 34 mismatches to R. helvetica 
(U59723) and was most closely related (99%) to Rickettsia sp. IRS3 
(AF140706) and R. sp. IRS4 (AF141906) found in I. ricinus ticks collected in 
Slovakia, and R. monacensis (DQ100163) reported in Germany.  
 
4.7 Phylogenetic analyses 
Phylogenetic analyses were based on the 348 bp long sequence of the gltA gene of 
14 sequenced tick pools (Fig. 2). These sequences were obtained from ten tick pools 
after amplification of the 381 bp fragment, from three tick pools after amplification of 
the 796 bp PCR-product and from one tick pool after amplification of the 476 bp 
fragment. Thirteen out of fourteen sequences clustered with R. helvetica (U59723). 
Only the tick pool #73 branched away from the remaining sequenced tick pools and 
was most closely related to R. monacensis (DQ100163), R. sp. IRS4 (AF141906) 
and R. sp. PoTiR6dt (EF501756) (Fig. 2).  
 
5 Discussion 
This study expands the knowledge on the distribution of R. helvetica infection 
by employing a newly developed sensitive real-time TaqMan PCR assay in 
ticks, foxes, dogs and humans within a geographic region (Canton of Zurich, 
Switzerland). We concentrated on the investigation of humans and canidae 
because both are known to develop disease when infected with SFG-
rickettsiae. While R. helvetica was frequently detectable in Ixodes spp. ticks, 
none of the 1.156 blood samples tested positive. Nonetheless, ticks collected 
from animals and particularly from cats were more frequently positive than 
  16
those collected from the vegetation. With one exception, all identified 
rickettsiae were assumed to be R. helvetica. In addition, a Rickettsia never 
described previously in Switzerland was identified according to the sequencing 
results.  
The herein described real-time TaqMan PCR assay amplifies a fragment of the 
23S rRNA gene of R. helvetica. A recently described assay for the R. helvetica 
23S (28) could not be used in the present study because the oligonucleotide 
sequences and the run conditions were not compatible with a standard 
TaqMan assay on our ABI real-time cyclers. Our newly designed PCR system 
did not amplify endosymbionts; the latter is of major concern when developing 
diagnostic PCR assay for rickettsiae and related agents. The assay was found 
to be more sensitive for the detection of R. helvetica than a previously 
described real-time TaqMan assay that detects the gltA gene of rickettsiae of 
the spotted fever and typhus group (32). This can be explained by the higher 
specificity of the primers and probe for R. helvetica of the newly designed 
assay compared to the published more generic assay (32). Thus, for most 
sensitive detection of R. helvetica the 23S rRNA gene assay should be used 
because with the gltA assay R. helvetica prevalence could be underestimated.  
The Ct difference between the two assays (23S and gltA) could be used as a 
marker for the presence of R. helvetica compared to other rickettsiae. Samples 
with lower Ct values for the 23S rRNA gene compared to the gltA gene were 
identified by sequencing to be R. helvetica (n=16). Remarkably, the one 
sample with a higher Ct value in the 23S rRNA assay was a Rickettsia species 
not yet reported in Switzerland. Therefore, although the 23S rRNA gene PCR 
assay was designed to specifically amplify only R. helvetica, other rickettsiae 
particularly so far uncharacterized strains may be amplified although probably 
with a low efficiency. We suggest using the above mentioned method of 
comparison of Ct values resulting from the two TaqMan PCR assays (23S and 
gltA) for screening purposes and further confirmation by sequencing of 
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discordant samples. The estimated prevalence of R. helvetica in approximately 
2,000 analyzed ticks was between 10 and 40%. Confirmed by sequence 
analyses, R. helvetica was the only detected rickettsial agent with the 
exception of one positive tick pool sample, which revealed a different 
Rickettsia species not yet reported in Switzerland. Its sequence was most 
closely related to those reported from ticks from Portugal (EF501756.1: 
Rickettsia sp. PoTiR6dt), Slovakia (AF141906.1: Rickettsia sp. IRS4) and 
Germany (DQ100163.1: R. monacensis). This observation is in accordance 
with other results recently obtained in Germany: R. monacensis was isolated 
and characterized from Ixodes ricinus ticks collected in Upper Palatine in 
South-Eastern Germany. The Rickettsia species was identified by sequencing 
of gltA, rOmpA and rOmpB genes. Based on the obtained data an identity of > 
99% between R. monacensis and R. spp. IRS3 and IRS4 could be 
demonstrated (Wölfel et al., personal communication). The results show that 
R. monancensis has a much larger area of distribution than known so far. 
Furthermore, the molecular characterization indicates that R. monacensis and 
the R. spp. IRS3 and IRS4 belong to only one single species. 
Investigation of tick populations can be used as an epidemiological tool to 
determine the importance of an infectious agent in a specific area. A high 
percentage of I. ricinus ticks collected from the vegetation was found PCR-
positive for R. helvetica. Interestingly, in ticks collected from animals the 
estimated prevalence was higher than in ticks collected from the vegetation. 
Our results are in agreement with a study by Nielsen and coworkers (15) in 
which the presence of R. helvetica was highest in adult ticks collected from 
dogs and roe deer. These findings might point to larger mammals as reservoir 
hosts for R. helvetica, an assumption which is further supported by a study 
from Inokuma and coworkers (9). The authors analyzed blood samples 
collected from Sika deer in Japan and found 8 out of 102 animals PCR-
positive for R. helvetica. Since deer are often infested with high numbers of 
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ticks, they can be important reservoir animals for tick-borne pathogens. 
Remarkably, in the present study more ticks from cats than from dogs were 
PCR-positive for R. helvetica. For all ticks collected from cats, the Ct values 
were lower in the 23S rRNA than in the gltA gene PCR assay. From an 
ongoing study we know that R. felis - that could potentially occur in feline 
samples but has not yet been detected in Switzerland - led to a higher Ct value 
in the 23S rRNA than in the gltA assay (S. Hornok, personal communications). 
From this we assume that the high prevalence observed in ticks from cats was 
not due to R. felis and, therefore, cats actually may be a reservoir for R. 
helvetica. In a study from Africa, up to 34% of the included cats were found 
seropositive for Rickettsia conorii, another member of the spotted fever group 
rickettsiae that is transmitted by Rhipicephalus sanguineus. The authors 
concluded that cats can be used as indicators for the presence of these 
organisms (14).  
Due to the high abundance and the broad host range of I. ricinus and the high 
prevalence of R. helvetica in this tick species, the likelihood of transmission of 
the agent to tick-exposed individuals should be high. Nonetheless, all blood 
samples from different mammals, including wild animals (foxes) and humans, 
tested PCR-negative. Several reasons have to be considered to explain this 
unexpected result. First, the sensitivity of our PCR assay may not have been 
sufficient. Rickettsia loads may be very low as it has been shown, e.g., for R. 
rickettsii in rickettsiemic patients (5) (10). However, this seems unlikely 
because the lower detection limit of the applied PCR assay was one copy per 
reaction, which calculates into 200 copies/ml blood. A second explanation 
could be a very focal distribution of R. helvetica leading to high geographic 
variations of the prevalence. This seems also unlikely because in the present 
study the majority of ticks and blood samples originated from the same region 
(Canton of Zurich). A third explanation could be a seasonal occurrence of 
rickettsiemia associated with the seasonal fluctuation of the tick vector I. 
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ricinus; we aimed to avoid this potential source of bias by collecting canine 
blood samples throughout an entire year. The lack of detection of R. helvetica 
in blood samples could also have resulted from an only short-lived 
bacteriemia. This has been demonstrated for other rickettsiae, such as R. 
rickettsii, which were detectable only up to 10 days after experimental infection 
of dogs (20). Thus infection might indeed have taken place, but the time point 
of the blood collection might not have been optimal. Yet, if bacteriemia is only 
short-lived in larger mammals, the likelihood of them being a major reservoir 
for R. helvetica is low.  
Nonetheless, despite all blood samples tested PCR-negative, a pathogenic 
potential of R. helvetica in animals should not be excluded. For comparison 
the 1,880 ticks collected from the vegetation in the Canton of Zurich were not 
only analyzed for R. helvetica but also for TBEV, the infectious agent leading 
to encephalitis, e.g., in humans and canidae. The exposure risk to R. helvetica 
was found to be 13-times higher (prevalence 11.7%) than that to TBEV 
(prevalence 0.9%). Therefore, we anticipate that R. helvetica infections may 
occur also in Swiss individuals as has been demonstrated in other countries 
with a high prevalence of R. helvetica in I. ricinus ticks (7, 15). Further studies 
are necessary to clarify this issue. The ability of our newly developed real-time 
PCR to detect even very low copy numbers and the specific nature of our 
assay make it a valuable tool to further evaluate the importance of R. helvetica 
infections
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6 Tables and Figures  
TABLE 1. Species, number, source and extraction methods of ticks, which were collected throughout Switzerland 
and number and percentage that tested PCR-positive for R. helvetica.  
 
Sample group Number of 
ticks / 
blood 
samples  
Source Origin Number 
of ticks 
pooled/ 
extraction
NA extraction gltA gene real-
time PCR positive 
(percentage) 
 
23S rRNA gene  
real-time PCR 
positive (percentage)
        
Ticks from vegetation 1880 vegetation ZH 10 MagNa Pure1 9.9% 11.7% 
        
        
Ticks from animals        
Ixodes sp. 712 39 cats CH/ZH3 1-3 DNeasy tissue kit4 40.9% 49.9% 
 1175 66 dogs CH/ZH6 1-4 DNeasy tissue kit 17.6% 28.3% 
 5 5 horses ZH - DNeasy tissue kit 120% 20% 
        
        
Blood samples 8847 dogs CH/ZH8 - MagNa Pure 0 0 
 58 foxes ZH - MagNa Pure 0 0 
  214 humans ZH - MagNa Pure 0 0 
1MagNA Pure LC Total Nucleic Acid Isolation Kit (Roche). 2(36): the sample consisted of 62 single ticks and 3 tick pools. 3The majority (83%) of these 
ticks had been collected from cats in the Canton of Zurich. 4Qiagen. 5 110 out of 117 samples as described previously (36); seven additional ticks had 
been collected from dogs in the Canton of Zurich. In total, 86 single ticks and 12 tick pools were included. 6The majority (56%) of these ticks had been 
collected from dogs in the Canton of Zurich. 7From the originally 889 dogs (34), 884 were included in the study; no sample was available anymore from 
5 dogs. 8The majority (70%) of these blood samples had been collected from dogs in the Canton of Zurich. ZH: Canton of Zurich; TI: Canton of Ticino; 
CH: Switzerland. 
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TABLE 2. Primers specific for the 23S rRNA gene of R. helvetica and the gltA gene 
of several rickettsiae used in this study. 
Target 
Oligo 
nucleotide Sequence Reference 
Apmlicon 
lengths 
23S-Gen         
Real-time 
PCR     
probe Rickhelv.170p 6FAM-AAC CGT AGC GTA CAC TTA-MGBNFQ This study 
forward Rickhelv.147f TTT GAA GGA GAC ACG GAA CAC A This study 
reverse Rickhelv.211r TCC GGT ACT CAA ATC CTC ACG TA This study 65bp 
Sequencing 
primer      
forward rhelv.159f ACG GAA CAC AGA ACC GTA GC This study 
reverse rhelv.365r CTG GAT ACC GTG GAT CAA GC This study 206bp 
forward rhelv.26f AAT GTG TGT AGC TAA CCG ATA CTA AT This study 
reverse rhelv.356r GTG GAT CAA GCC ATG ATA TGA C This study 330bp 
           
gltA-Gen          
Real-time 
PCR     
probe CS-P FAM-TGC AAT AGC AAG AAC CGT AGG CTG GAT G-BHQ 
1 
forward CS-F TCG CAA ATG TTC ACG GTA CTT T 
1 
reverse CS-R TCG TGC ATT TCT TTC CAT TGT G 
1 74bp 
Sequencing 
primer      
forward Rp877p GGG GAC CTG CTC ACG GCG G 
2 
reverse Rp1258n ATT GCA AAA AGT ACA GTG AAC A 
2 381bp 
forward CS1f ATG ACT AAT GGC AAT AAT AA 
3 
reverse CS477r TAA GTT CGT AGT CTG CTT CC 
3 496bp 
forward CS477f GGA AGC AGA CTA CGA ACT TA 
3 
reverse CS1273r GAT AAC CAG TGT AAA GCT GT 
3 796bp 
forward Rp414f AAA CAG GTT GCT CAT CAT TC 
4 
reverse CS477r TAA GTT CGT AGT CTG CTT CC 
3 163bp 
forward CS1f ATG ACT AAT GGC AAT AAT AA 
3 
reverse CS353r GAA TGA TGA GCA ACC TGT TT 
3 353bp 
forward Rp877p GGG GAC CTG CTC ACG GCG G 
2 
reverse CS1273r GAT AAC CAG TGT AAA GCT GT 
3 476bp 
1 (32); 2 (24); 3 (27); 4 (29). 6FAM: 6-carboxyfluorescein; MGB: minor groove binder; NFQ: non-
fluorescent quencher; BHQ: black-hole quencher. 
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1. CS1f/CS477r: 496 bp
2. CS477f/CS1273r: 796 bp
3. Rp877p/CS1273r: 476 bp
4. Rp877p/Rp1258n: 381 bp
5. Rp414f/CS477r: 163 bp
6. CS1f/CS353r: 353 bp
7. gltA TaqMan PCR: CS-F/CS-P/CS-R: 74 bp
1 2
3
4
56
7
 
FIGURE 1. Schematic diagram of the sequencing procedures for the gltA 
gene. The amplification of six different amplicons was attempted. For 
sequencing primers see TABLE 2. 
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R.africae/U59733
R.conorii/U59730
R.sibirica/U59734
R.slovaca/U59725
R.rickettsii/U59729
R.parkeri/U59732
R.honei/AF018074
R.japonica/U59724
R.aeschlimanni/U59722
R.massiliae/U59719
R.rhipicephali/U59721
R.montana/U74756
R.akari/U59717
R.australis/U59718
R.sp IRS3/AF140706
R.sp.IRS4/AF141906
R.monacensis strain IrR/DQ100163
R.sp CH-73 4/EU359302
R.sp PoTiR6dt/EF501756
R.canadensis/U59713
R.helvetica 166 4/EU359288
R.helvetica 21 2/EU359286
R.helvetica 41 2/EU359287
R.helvetica 44 4/EU359294
R.helvetica 119 4/EU359297
R.helvetica 36 4/EU359290
R.helvetica 88 4/EU359301
R.helvetica 87 4/EU359296
R.helvetica/U59723
R.helvetica 40 4/EU359292
R.helvetica 20 2/EU359285
R.helvetica 39 4/EU359291
R.helvetica 15 3/EU359289
R.helvetica 80 4/EU359295
R.typhi Wilmington/U59714
R.prowazekii/U59715
R. sp AB Bacterium/U59712
R.bellii/U59716
99
99
90
97
81
72
96
0.005
 
FIGURE 2. Phylogenetic tree. 
Boostrap phylogenetic tree of 14 partial gltA sequences from tick pools (1,000 
Bootstrap resamplings). Only bootstrap values > 70% are shown. The bar 
represents mean number of differences per 100 sites. Sequences of ten tick 
pools (EU359288, EU359290-EU359292, EU359294-EU359297 and 
EU359301-EU359302) were derived from a 381 bp PCR fragment, of three 
pools (EU359285-EU359287) from a 796 bp PCR fragment and of one pool 
(EU359289) from a 476 bp PCR fragment. 
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